Researchers at micromod Partikeltechnologie GmbH are using the Zetasizer Nano particle characterisation system from Malvern Instruments, equipped with an MPT-2 Autotitrator and degasser, to determine particle size and to measure the zeta potential of nanoparticles as a function of pH.
Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, and Nycomed, a privately owned global pharmaceutical company, announced today that Eurand has entered into an exclusive commercialisation, license and supply agreement with Nycomed for Russia and the Commonwealth of Independent States (CIS), as well as Georgia and Mongolia. Financial terms were not disclosed.
Malvern Instruments will run two one-day short courses as part of the established program at Pittcon 2011on 13-18 March 2011 in Atlanta, GA, US.
Meet Biovian at the BioEurope 2011 Spring partnering conference, taking place on 14-16 March 2011 in Milan, Italy.
CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine.
Euroscreen announced today that it has entered into a worldwide collaboration and licensing agreement with Ortho-McNeil-Janssen Pharmaceuticals.
Alliance Life Sciences Consulting Group, Inc., a leading management and technology consultancy recognized for defining, deploying and supporting business critical applications, has chosen CPR Strategic Marketing Communications to direct its business-to-business public relations and marketing communications initiatives.
Lonza has chosen IDBS, a leading global provider of data management and analytics solutions to R&D and healthcare organisations, to provide an electronic data management and execution solution for mammalian cell culture process development. Lonza, a world leader in biopharmaceutical development and production, will deploy IDBS’s Bioprocess Execution System to optimise the management of process development data and drive operational excellence to Lonza customers.
Investigator Location Services, Inc. (ILS), the largest study broker, reported the operational results since the companies launch in July 2001. 311 sponsor and CRO companies have used ILS to recruit over 7200 investigators on 700+ protocols including difficult to place projects. ILS investigator recruiting services are free to sponsors and CROs as investigators pay ILS fees.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.